Openhouse Procedure Various Active Pharmaceutical Ingredients From October 1St 2024

Deadline: 05 Aug 2026

Germany

Ref. No.: 5597729

EMD:Ref Document

Bid Value: Ref Document

194 Days Left

Open Framework Agreement On Drug Discounts In Accordance With Section 130A Paragraph 8 Sgb V With The Possibility Of Joining At Any Time So Called Approval Model 2024 05

Deadline: 05 May 2026

Germany

Ref. No.: 5508686

EMD:Ref Document

Bid Value: Ref Document

102 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 5485044

EMD:Ref Document

Bid Value: Ref Document

342 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 5460438

EMD:Ref Document

Bid Value: Ref Document

342 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 5457173

EMD:Ref Document

Bid Value: Ref Document

342 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 5450913

EMD:Ref Document

Bid Value: Ref Document

342 Days Left

Drug Contracts With An Option To Join

Deadline: 01 May 2026

Germany

Ref. No.: 5310892

EMD:Ref Document

Bid Value: Ref Document

98 Days Left

Open House Drug Discount Agreements Rivaroxaban Film Coated Tablets Except With A Strength Of 2 5 Mg Atc B01Af01

Deadline: 05 Apr 2026

Germany

Ref. No.: 5306291

EMD:Ref Document

Bid Value: Ref Document

72 Days Left

Conclusion Of Non Exclusive Discount Agreements In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 5266211

EMD:Ref Document

Bid Value: Ref Document

342 Days Left

Medicines With The Active Ingredient Fampridine Atc N07Xx07

Deadline: 31 Mar 2026

Germany

Ref. No.: 5229599

EMD:Ref Document

Bid Value: Ref Document

67 Days Left

Medicines With The Active Ingredient Tiotropium Bromide Atc R03Bb04 Except In The Dosage Form Hard Capsules With Powder For Inhalation

Deadline: 31 Mar 2026

Germany

Ref. No.: 5227518

EMD:Ref Document

Bid Value: Ref Document

67 Days Left

Medicines With The Active Ingredient Dupilumab Atc D11Ah05

Deadline: 31 Mar 2026

Germany

Ref. No.: 5227070

EMD:Ref Document

Bid Value: Ref Document

67 Days Left

Medicines With The Active Ingredient Combination Formoterol Glycopyrronium Bromide And Beclometasone Atc R03Al09

Deadline: 31 Mar 2026

Germany

Ref. No.: 5226698

EMD:Ref Document

Bid Value: Ref Document

67 Days Left

Medicines With The Active Ingredient Combination Vilanterol Umeclidinium Bromide And Fluticasone Furoate Atc R03Al08

Deadline: 31 Mar 2026

Germany

Ref. No.: 5226107

EMD:Ref Document

Bid Value: Ref Document

67 Days Left

Open House Drug Discount Agreements Calcipotriol And Betamethasone Excluding Ointments Atc D05Ax22

Deadline: 05 Apr 2026

Germany

Ref. No.: 5166613

EMD:Ref Document

Bid Value: Ref Document

72 Days Left

Discover Tenders by Miscellaneous Pharmaceuticals Sector

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Discover Tenders by Miscellaneous Pharmaceuticals Sector

Filter Your Search

FREE Trial plan for all new users!